Browsing by Subject "Diagnosis, Dual (Psychiatry)"
Now showing items 1-6 of 6
-
Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey.
(The American journal of psychiatry, 1999-08)OBJECTIVE: This study sought to determine how comorbidity of psychiatric and substance abuse disorders affects the likelihood of using mental health services. METHOD: The analysis was based on data on adults aged 18-54 years ... -
Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data.
(Drug and alcohol dependence, 2015-11)BACKGROUND:Comorbid diabetes and substance use diagnoses (SUD) represent a hazardous combination, both in terms of healthcare cost and morbidity. To date, there is limited information about the association of SUD and related ... -
Substance use disorders and psychiatric comorbidity in mid and later life: a review.
(International journal of epidemiology, 2014-04)Globally, adults aged 65 years or older will increase from 516 million in 2009 to an estimated 1.53 billion in 2050. Due to substance use at earlier ages that may continue into later life, and ageing-related changes in medical ... -
Use of substance abuse treatment services by persons with mental health and substance use problems.
(Psychiatric services (Washington, D.C.), 2003-03)OBJECTIVES: This study provided population estimates of mental syndromes and substance use problems and examined whether the co-occurrence of mental health and substance use problems was associated with the use of substance ... -
Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults.
(Journal of psychiatric research, 2013-04)To examine prevalences of substance use disorders (SUD) and comprehensive patterns of comorbidities among psychiatric patients ages 18-64 years (N = 40,099) in an electronic health records (EHR) database.DSM-IV diagnoses ... -
Vintage treatments for PTSD: a reconsideration of tricyclic drugs.
(Journal of psychopharmacology (Oxford, England), 2015-03)Serotonin (SSRI) and serotonin-norepinephrine (SNRI) reuptake inhibitors (SSRI) are the first-line recommended drug treatments for post-traumatic stress disorder (PTSD); but despite their benefits, much residual pathology ...
